NASDAQ · Biotechnology

Iambic Therapeutics, Inc. (IAM) Stock

$14.26 -2.79% NASDAQ: IAM Healthcare

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery.

Valuation

Metric	Value
Price	$14.26
Market Cap	$133.69M
P/E Ratio	—
P/B Ratio	—
P/S Ratio	—
EPS (TTM)	—
52-Week High	$25.00
52-Week Low	$13.02
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	—
ROA	—
ROCE	—
Gross Margin	—
Operating Margin	—
Net Margin	—
Debt/Equity	—
Current Ratio	—

Latest News

Another Biotech IPO Pops on Rough Day for Broader Market Barrons.com · Oct 16, 2026 Cathie Wood-Backed Biotech IPO Pops in Debut Barrons.com · Oct 15, 2026 Iambic Announces Pricing of Initial Public Offering Business Wire · Oct 14, 2026 Toogood Gold Narrows Table Mountain Targets as Two Major Gold Corridors Take Shape Insider Monkey · Sep 28, 2026

About Iambic Therapeutics, Inc.

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.

Iambic Therapeutics, Inc. is headquartered in US.

Iambic Therapeutics, Inc. (IAM) stock trades at $14.26 with a market capitalization of $133.69M. Over the past 52 weeks the stock has ranged between $13.02 and $25.00, and currently trades 43.0% below its 52-week high.

Official website: www.iambic.ai

Iambic Therapeutics, Inc. (IAM) — frequently asked questions

What is Iambic Therapeutics, Inc. (IAM) stock price today?

Iambic Therapeutics, Inc. (IAM) is currently trading at $14.26, down 2.79% today.

What is Iambic Therapeutics, Inc.'s market cap?

Iambic Therapeutics, Inc. has a market capitalization of $133.69M.

What sector is IAM in?

Iambic Therapeutics, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is IAM listed on?

Iambic Therapeutics, Inc. trades on NASDAQ under the ticker IAM.

What is IAM's 52-week range?

Over the last year Iambic Therapeutics, Inc. has traded between $13.02 and $25.00.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Screens IAM currently matches

On the figures above, Iambic Therapeutics, Inc. passes the filters for 1 of our ready-made screens, among them Micro Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Micro Cap Stocks

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.